Accessorize At Your Own Risk: Draft Guidance Clarifies Device Add-On Regs
This article was originally published in The Tan Sheet
Executive Summary
FDA says it will classify risk for accessories separate from a parent medical device, which could reduce requirements in some cases, but could call for more proactive regulatory efforts by companies, experts suggest.